Stocks and Investing Stocks and Investing
Wed, September 22, 2021
Tue, September 21, 2021

Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $16 on, Sep 21st, 2021


Published on 2024-10-27 17:57:23 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $19 to $16 on, Sep 21st, 2021.

Gregory, nor any peers, have made any analyst calls on VRCA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources